Primary salivary gland tumors. A report of 703 cases.

Günhan, Ömer; Celasun, Bülent; Ruacan, Şevket

doi:10.2334/josnusd1959.31.443

Cited by 7 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Günhan et al studied a series of 703 patients (mean age: 47.1 yr; range: 2 to 80) with primary epithelial tumors that involved both the major and minor salivary glands. 43 Th ey found that males were more aff ected than females by a margin of 59 to 41%. Th e peak incidence of malignant tumors occurred in the sixth decade.…”

Section: Discussionmentioning

confidence: 97%

Salivary Gland Cancer in Patients Younger than 30 Years

et al. 2011

View full text Add to dashboard Cite

Previous research has shown that salivary gland tumors are rare in the young population. A clinical diagnosis has to be made very carefully because the proportion of malignancies is higher in children than in adults. We present a review of cases of malignant salivary gland carcinoma (SGC) in patients younger than 30 years of age. Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) 17 Registry. A total of 763 patients younger than 30 years with carcinoma of a major salivary gland from 1973 to 2004 were identifi ed within the SEER database. Th e most common salivary gland cancer was mucoepidermoid parotid gland carcinoma. Th e incidence of all major salivary gland carcinomas increased with increasing patient age. Th e 5-year relative survival rate for salivary gland carcinomas in our population was calculated according to the Kaplan-Meier analysis in each age group. Relative 5-year survival was 100% in the 1 patient younger than 1 year, 50.0% in the 1-to 4-year-old group; 87.2% among the 5-to 9-year-olds; 97.0% among the 10-to 14-year-olds; 95.0% among the 15-to 19-yearolds; 95.1% among the 20-to 24-year-olds; and 93.6% in the 25-to 29-year-old group. We found that SGC aff ects patients of all ages, even children in the fi rst year of life. It is essential for physicians to detect salivary gland neoplasms promptly and to evaluate them thoroughly when they are found in children. ASL Pharmacy® is also dispensing the AeroNeb® Go and the NeilMed® Sinus Rinse Bottle upon request. *ASL is not a Medicaid provider. NasoNeb is a trademark of MedInvent, LLC.

show abstract

Section: Discussionmentioning

confidence: 97%

Salivary Gland Cancer in Patients Younger than 30 Years

et al. 2011

View full text Add to dashboard Cite

show abstract

“…The occurrence of undifferentiated carcinoma is about 3-4% of all parotid gland tumors, 1-8.8% of all submandibular gland tumors, and is very rare in the minor salivary glands [1], GUNHAN et al [2] reported 703 cases of major and minor salivary gland tumors. Undifferentiated carcinoma accounted for only 6 cases, all of which appeared in the parotid gland.…”

Section: Discussionmentioning

confidence: 99%

A case of undifferentiated carcinoma arising in the mandible.

Ishii

Tanaka

Koizumi

et al. 1990

The Journal of Nihon University School of Dentistry

View full text Add to dashboard Cite

show abstract

“…Carcinoma in pleomorphic adenoma represents from 1.4 to 4.1% of all salivary gland tumors (4,12). It comprises 1.3 -3.6% of the major salivary gland tumors, which often occur in the parotid gland and submandibular glands, and 1.0 -17.5% of the minor salivary gland tumors (2-15).…”

Section: Discussionmentioning

confidence: 99%

“…It occurs most often in the parotid and submandibular glands of the major salivary glands in elderly people (1), and occasionally occurs in the minor salivary gland, particularly in the palate (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15).…”

Section: Introductionmentioning

confidence: 99%